Delivery Order SPE2DR25D3111-SPE2DR26FF3MK
- Not listed
- The Defense Logistics Agency awarded a $4,719.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a non-set-aside competitive award delivered to the Conshohocken, Pennsylvania location, reflecting AmerisourceBergen's ongoing role as a critical pharmaceutical and medical supply vendor within the federal healthcare procurement ecosystem. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,873.67 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, effective December 3, 2025, with completion targeted for December 4, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The product will be delivered to the awardee's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $4,653.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 5, 2025. This competitive, non-set-aside award reflects a firm fixed price contract structure and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Lidocaine 5% Patch (30-count units) with a ceiling value of $5,832.68. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $2,421.44, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $5,418.73. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a $13.75K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This non-set-aside, competitively awarded delivery order represents a single-item pharmaceutical transaction fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3MKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,857.80 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, effective December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor for federal military healthcare procurement. As the prime contractor on the DLA's comprehensive Pharmaceutical Prime Vendor program, the company supplies a broad portfolio of medications and medical supplies—including specialty pharmaceuticals, generic and brand-name drugs, vaccines, and medical devices—to support Defense Health Agency operations and other federal healthcare systems worldwide. The firm fixed-price delivery order structure and non-set-aside designation reflect competitive procurement practices consistent with AmerisourceBergen's established federal contracting relationships in pharmaceutical distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 12/7/25 |